GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » iAnthus Capital Holdings Inc (OTCPK:ITHUF) » Definitions » Net Margin %

iAnthus Capital Holdings (iAnthus Capital Holdings) Net Margin % : -45.73% (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is iAnthus Capital Holdings Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. iAnthus Capital Holdings's Net Income for the three months ended in Dec. 2023 was $-18.7 Mil. iAnthus Capital Holdings's Revenue for the three months ended in Dec. 2023 was $40.9 Mil. Therefore, iAnthus Capital Holdings's net margin for the quarter that ended in Dec. 2023 was -45.73%.

The historical rank and industry rank for iAnthus Capital Holdings's Net Margin % or its related term are showing as below:

ITHUF' s Net Margin % Range Over the Past 10 Years
Min: -2865.08   Med: -332.48   Max: -38.17
Current: -48.11


ITHUF's Net Margin % is ranked worse than
79.63% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 3.25 vs ITHUF: -48.11

iAnthus Capital Holdings Net Margin % Historical Data

The historical data trend for iAnthus Capital Holdings's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iAnthus Capital Holdings Net Margin % Chart

iAnthus Capital Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only -389.61 -206.61 -38.17 -275.34 -48.12

iAnthus Capital Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -116.40 -50.59 -52.04 -44.72 -45.73

Competitive Comparison of iAnthus Capital Holdings's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, iAnthus Capital Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iAnthus Capital Holdings's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, iAnthus Capital Holdings's Net Margin % distribution charts can be found below:

* The bar in red indicates where iAnthus Capital Holdings's Net Margin % falls into.



iAnthus Capital Holdings Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

iAnthus Capital Holdings's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-76.621/159.237
=-48.12 %

iAnthus Capital Holdings's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-18.695/40.879
=-45.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


iAnthus Capital Holdings  (OTCPK:ITHUF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


iAnthus Capital Holdings Net Margin % Related Terms

Thank you for viewing the detailed overview of iAnthus Capital Holdings's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


iAnthus Capital Holdings (iAnthus Capital Holdings) Business Description

Traded in Other Exchanges
Address
420 Lexington Avenue, Suite 414, New York, NY, USA, 10170
iAnthus Capital Holdings Inc owns and operates licensed cannabis cultivators, processors, and dispensaries throughout the United States. The company's operating segments include the Eastern Region and Western Region. It generates a majority of its revenue from the Eastern Region. The Eastern Region includes the company's operations in Florida, Maryland, Massachusetts, New York, New Jersey, Vermont, and its CBD business. Its Western Region includes the company's operations in Arizona, Colorado, and Nevada.
Executives
Proud Richard C. Jr. director, officer: CEO and Director 8253 PARSONS PASS, NEW ALBANY OH 43054
Alexander Shoghi director SUITE 1550, 300 WEST 6TH STREET, AUSTIN TX 78701
John Alexander Paterson director 2 WENDIGO WAY, TORONTO A6 M6S2T9
Gotham Green Partners Llc 10 percent owner 1437 4TH STREET, SANTA MONICA CA 90401
Philippe Faraut officer: Chief Financial Officer 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Kenneth W Gilbert director C/O THE WENDY'S COMPANY, ONE DAVE THOMAS BLVD., DUBLIN OH 43017
Julius Kalcevich officer: Chief Financial Officer 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Robert R Galvin officer: Interim CEO and COO
Senvest Management, Llc director, 10 percent owner, other: (See Remarks) 540 MADISON AVENUE, 32ND FLOOR, NEW YORK NY 10022
Marco Dattanasio director 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Scott Herman Cohen director 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Zachary Arrick director 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Mich J Mathews-spradlin director ONE DAVE THOMAS BLVD., DUBLIN OH 43017
Oasis Investments Ii Master Fund Ltd. 10 percent owner UGLAND HOUSE PO BOX 309, GRAND CAYMAN E9 KY1-1104
Seth Fischer 10 percent owner C/O OASIS MANAGEMENT (HONG KONG) LLC, 21/F MAN YEE BUILDING, 68 DES VOEUX ROAD, CENTRAL K3